Ignacio Melero

Has grant

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

Células dendríticas de cross-priming como vacunas en una estrategia de inmunoterapia para cánceres renales y de urotelio

Open Date: 2023-01-01

Close Date: 2026-12-01

Grant: Close

Evaluating the therapeutic potential of immunosuppressive paracrine cytokines in the tumor microenvironment of metastatic lesions (iParaCyts)

Open Date: 2022-12-01

Close Date: 2025-11-01

Grant: Close

Explorando la biodiversidad marina en la búsqueda de TERapias INMUNo-oncológicas (TERINMUN)

Open Date: 2022-03-01

Close Date: 2024-12-01

Grant: Close

Nanovectors for directed, loco-regional and controlled intravenous administration of antitumor drugs. Strategies to minimize adverse effects and maximize therapeutic response. (ONCOLIBERYX

Open Date: 2022-03-01

Close Date: 2025-03-01

Grant: Close

I Beca Baselga

Open Date: 2022-01-01

Close Date: 2025-01-01

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Mikel Ariz

Associate Professor

Universidad de Navarra

SPAIN

View details

Anja Williams

Scripps Research Institute

UNITED KINGDOM

View details

Ignacio Matos

Clinica Universidad de Navarra

SPAIN

View details

Belen Palencia

Clinica Universidad de Navarra

SPAIN

View details

Johann S de Bono

Head of Clinical Studies Division

Institute of Cancer Research

UNITED KINGDOM

View details

Alvaro Teijeira

Centro de Investigación Médica Aplicada, Universidad de Navarra

SPAIN

View details

Maite Alvarez

SPAIN

View details

David Withers

Reader in Cellular Immunology

University of Birmingham

UNITED KINGDOM

View details

Kristoffer Rohrberg

Ass. Professor

Faculty of Health and Medical Sciences, University of Copenhagen

DENMARK

View details

David Hardisson

Full Professor (Catedrático)

Universidad Autónoma de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ignacio Melero

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (21)

The Dark Side of NK Cells in Cancer Immunotherapy

A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors

Routing immunomodulatory cytokine-encoded mRNAs to the omentum: turning an enemy into an ally in peritoneal metastasis

The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis

Immunocytokines and cytokine neutralization for cancer immunotherapy

Antigen-presenting mast cells are new players in breast cancer immunotherapy

Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse

Barriers to publishing early phase clinical trials: the oncologists’ perspective

Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours

4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.

Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images

Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy

Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross‐priming

Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma.

mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy.

Druggable targets in cytokine release syndromes

A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors

A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors

Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma

Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images

mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy

Collaborators (10)

Mikel Ariz

Anja Williams

Ignacio Matos

Belen Palencia

Johann S de Bono

Alvaro Teijeira

Maite Alvarez

David Withers

Kristoffer Rohrberg

David Hardisson

Make your next move.